Advanced search
Showing results 3461 to 3480 on 8509 in total
-
No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials
M. Al-Gobari, H.H. Le, M. Fall, François Gueyffier, B. Burnand
-
Quality of qualitative studies centred on patients in family practice: a systematic review
Benedicte Eschalier, Stéphane Descamps, Bruno Pereira, Hélène Vaillant-Roussel, Guillaume Girard, Stéphane Boisgard, Emmanuel Coudeyre, Ara Nazarian, M. Rehman, B.V. Tudrej, J. Soustre, M. Buisson, P. Archambault, D. Pouchain, François Gueyffier, J.-L. Faillie, C. Perault-Pochat, C. Cornu, R. Boussageon, Benoit Cambon, Philippe Vorilhon, Laurence Michel, Jean-Sébastien Cadwallader, Isabelle Aubin-Auger, Hélène Vaillant Roussel
-
Référentiel ECRIN pour la conformité aux bonnes pratiques de gestion des données des essais cliniques multinationaux
Catherine Cornu, Anne Donche, Carine Coffre, Amélie Le Gouge, Boulkedid Rym, Isabelle Vaugier, Frédéric Barbot, Alain Leizorovicz, Nadine Juge, Céline Giraud, François Gueyffier, Alexandra Félin, Thibault Mura, Hugues Chevassus, Christine Binquet, Comité de Pilotage Du Groupe de Travail Harmonisation Des Procédures de Réseau Des Cic
-
Metformin as firstline treatment for type 2 diabetes: are we sure?
R. Boussageon, François Gueyffier, Catherine Cornu
-
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals
G. Taverny, Y. Mimouni, A. Ledigarcher, P. Chevalier, L. Thijs, J.M. Wright, François Gueyffier
-
Impact of Aldosterone Antagonists on Sudden Cardiac Death Prevention in Heart Failure and Post-Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
H.-H. Le, C. El-Khatib, M. Mombled, F. Guitarian, M. Al-Gobari, M. Fall, P. Janiaud, I. Marchant, Michel Cucherat, T. Bejan-Angoulvant, François Gueyffier
-
One-step partial or complete caries removal and bonding with antibacterial or traditional self-etch adhesives: study protocol for a randomized controlled trial
Cyril Villat, Jean-Pierre Attal, Nathalie Brulat, Franck Decup, Sophie Doméjean, Elisabeth Dursun, Hélène Fron-Chabouis, Bruno Jacquot, Michèle Muller Bolla, Nelly Plasse-Pradelle, Laurent Roche, Delphine Maucort-Boulch, Patrice Nony, Kerstin Gritsch, Pierre Millet, François Gueyffier, Brigitte Grosgogeat
-
Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study
C. Vale, L. Rydzewska, M. Rovers, J. Emberson, François Gueyffier, L. Stewart
-
Impact of the reduction of calcineurin inhibitors on renal function in heart transplant patients: a systematic review and meta-analysis
Catherine Cornu, C. Dufays, Ségolène Gaillard, François Gueyffier, M. Redonnet, Laurent Sebbag, A. Roussoulieres, C. A. Gleissner, J. Groetzner, H. B. Lehmkuhl, L. Potena, L. Gullestad, M. Cantarovich, P. Boissonnat
-
Cardiovascular Events and Bleeding Risk Associated With Intravitreal Antivascular Endothelial Growth Factor Monoclonal Antibodies: Systematic Review and Meta-analysis
M. Thulliez, D. Angoulvant, M. L. Le Lez, Annie-Pierre Jonville-Bera, P. J. Pisella, François Gueyffier, T. Bejan-Angoulvant
-
Guidelines for Managing High Blood Pressure
Dk. Cundiff, François Gueyffier, Jm. Wright
-
Comparison of an effect-model-law-based method versus traditional clinical practice guidelines for optimal treatment decision-making: application to statin treatment in the French population
R. Kahoul, François Gueyffier, E. Amsallem, M. Haugh, I. Marchant, F. H. Boissel, Jp. Boissel
-
Multivariate meta-analysis using individual participant data
R. D. Riley, M. J. Price, D. Jackson, M. Wardle, François Gueyffier, J. Wang, J. A. Staessen, I. R. White
-
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: What is the level of evidence?
R. Boussageon, François Gueyffier, Catherine Cornu
-
Improving risk prediction performance for a better guidelines application
I. Marchant, T. Bejan-Angoulvant, Hh. Le, François Gueyffier
-
Études pharmaco-épidémiologiques : quels niveaux de preuve et comment les atteindre ?
M. Lapeyre-Mestre, C. Sapède, N. Moore, P. Bilbault, P. Blin, D. Chopy, D. Evans, François Gueyffier, L. Lacoin, M. Malbezin, J. Micallef, D. Morlet-Vigier, S. Muller, E. Oger, Y. Plétan, Gérard Pons, P. Verpillat, C. Vigneau
-
Correspondance à propos de l\textquoterightarticle \guillemotleft Objectifs glycémiques dans la prise en charge du diabète de type 2 \guillemotright
R. Boussageon, François Gueyffier, C. Cornu
-
Clinically Relevant Efficacy of Insulin Therapy in Patients with Type 2 Diabetes
R. Boussageon, J. M. Gamble, François Gueyffier, C. Cornu
-
Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality
Sylvie Erpeldinger, Laure Fayolle, Rémy Boussageon, Marie Flori, Xavier Lainé, Moreau Alain, François Gueyffier
-
Beta-blockers for the prevention of sudden cardiac death in heart failure patients: a meta-analysis of randomized controlled trials
M. Al-Gobari, C. El Khatib, F. Pillon, François Gueyffier